7Baggers
Quarterly
Annual
    Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 
      
                  
      operating activities:
                  
      net income
    30,111,000 87,828,000 11,094,000 -21,425,000 -57,578,000 -9,006,000 42,412,000 -94,712,000 40,011,000 35,674,000 -9,748,000 53,206,000 -262,497,000 162,804,000 
      adjustments to reconcile net income to net cash from operating activities:
                  
      equity-based compensation
    209,622,000 205,832,000 308,457,000 242,405,000 227,542,000 227,908,000 205,813,000 136,650,000 155,166,000 157,293,000 153,514,000 143,149,000 145,140,000 185,911,000 
      performance allocation compensation
    233,437,000 298,705,000 376,229,000 223,637,000 133,753,000 196,434,000 319,028,000 -120,770,000 172,077,000 221,341,000 41,949,000 149,495,000 -298,026,000 523,138,000 
      net incomees from investment activities
    791,000 2,087,000             
      capital allocation-based income
    -351,463,000 -491,421,000 -549,166,000 -330,670,000 -221,394,000 -311,776,000 -453,234,000 205,794,000 -276,171,000 -331,674,000 -89,156,000 -227,628,000 398,237,000 -837,705,000 
      depreciation and amortization
    30,808,000 31,382,000 37,942,000 32,400,000 32,079,000 32,965,000         
      non-cash lease expense
    13,934,000 14,176,000             
      other non-cash activities
    13,774,000 2,063,000 -16,486,000 40,223,000 12,227,000 7,892,000 51,917,000 12,975,000 17,907,000 17,829,000 -4,958,000 3,907,000   
      changes in operating assets and liabilities:
                  
      purchases of investments
    -206,966,000 -191,135,000 -343,498,000 -277,105,000 -77,109,000 -165,109,000 -96,712,000 -9,703,000 -175,590,000 -21,113,000 -37,978,000 -27,642,000 -18,176,000 -25,297,000 
      proceeds from investments
    610,833,000 430,412,000 617,321,000 194,602,000 264,014,000 384,595,000 147,489,000 290,246,000 188,141,000 172,602,000 500,779,000 52,364,000 352,060,000 662,481,000 
      due from affiliates
    -75,926,000 537,000 -6,049,000 -4,600,000 -127,370,000 119,157,000 54,814,000 -34,188,000 17,389,000 3,253,000 -17,478,000 69,217,000 -40,315,000 -53,802,000 
      other assets
    -10,148,000 -4,454,000 -28,320,000 -20,325,000 27,657,000 -4,075,000 -28,706,000 -149,000 -765,000 -14,855,000 -14,319,000 5,280,000 -1,340,000 -25,514,000 
      accounts payable and accrued expenses
    98,699,000 27,960,000 -227,226,000 35,314,000 138,569,000 105,953,000 -393,329,000 74,082,000 36,125,000 51,580,000 -127,092,000 23,313,000 15,142,000 74,402,000 
      due to affiliates
    -21,247,000 39,286,000 -15,334,000 33,872,000 -43,052,000 51,149,000 -145,663,000 1,021,000 -46,295,000 29,104,000 -26,587,000 40,416,000 -63,777,000 37,420,000 
      accrued performance allocation compensation
    -161,938,000 -236,959,000 -314,353,000 -78,906,000 -105,836,000 -148,033,000 -206,124,000 -24,568,000 -8,594,000 -265,738,000 -141,242,000 -192,728,000 -335,806,000 -2,599,000 
      other liabilities
    -28,454,000 -18,111,000 -37,678,000 -8,973,000 -5,579,000 -56,539,000 -14,640,000 -11,230,000 -10,878,000 -3,535,000 -9,908,000 -1,184,000 -7,966,000 -3,457,000 
      net cash from operating activities
    385,867,000 198,188,000 -188,074,000 68,932,000 214,575,000 436,713,000 -512,040,000 692,256,000 504,502,000 35,800,000 587,279,000 84,262,000 -9,265,000 713,602,000 
      investing activities:
                  
      acquisition of tpg angelo gordon
                  
      purchases of fixed assets
    -3,084,000 -6,347,000 -1,463,000 -10,553,000 -6,451,000 -9,664,000 -6,189,000 -5,585,000 -4,058,000 -896,000 -120,000 -184,000 -893,000 -1,252,000 
      net cash from investing activities
    -3,084,000 -6,347,000 -1,463,000 -10,553,000 -7,108,000 -25,341,000 -363,024,000 -5,585,000 -4,058,000 -896,000 -120,000 -184,000 -2,072,000 -636,000 
      financing activities:
                  
      proceeds from debt obligations
    224,000,000 255,000,000 70,000,000 100,000,000 1,218,500,000 501,000,000       
      repayment of debt obligations
    -97,000,000 -54,000,000 -118,000,000 -919,500,000       
      issuance costs on debt obligations
      -153,000 -16,479,000         
      withholding taxes paid on net settlement of equity-based awards
    -1,592,000 -180,112,000 -5,141,000 -991,000 -3,491,000 -58,048,000 -360,000 -29,000 -457,000 -6,032,000     
      contributions from holders of other non-controlling interests
    31,504,000 62,212,000 92,032,000 91,001,000 36,858,000 1,043,000 11,700,000 1,307,000 5,971,000 2,791,000  524,000   
      dividends/distributions
    -221,486,000 -260,877,000 -205,982,000 -204,762,000 -210,528,000 -211,219,000  -95,878,000 -143,539,000 -207,090,000  -209,778,000   
      settlement of contingent liabilities
                  
      tax receivable agreement payments
                  
      net cash from financing activities
    -92,839,000 -177,777,000 -167,091,000 -14,752,000 -177,314,000 14,297,000  -355,601,000 -538,925,000 -210,331,000    -231,076,000 
      net change in cash, cash equivalents and restricted cash
    289,944,000 14,064,000  43,627,000 30,153,000 425,669,000    -175,427,000     
      cash, cash equivalents and restricted cash, beginning of period
    821,192,000  678,371,000    1,120,650,000     
      cash, cash equivalents and restricted cash, end of period
    289,944,000 835,256,000  43,627,000 30,153,000 1,104,040,000    945,223,000     
      supplemental disclosures of other cash flow information:
                  
      cash paid for income taxes
    18,292,000 6,839,000  3,455,000 15,221,000 5,050,000         
      cash paid for interest
    18,318,000 27,683,000  33,047,000 4,919,000 11,902,000         
      reconciliation of cash, cash equivalents and restricted cash, end of period:
                  
      cash and cash equivalents
    290,056,000 821,971,000  43,482,000 30,296,000 1,090,713,000 4,059,000 316,000 722,000 1,185,000 1,149,000 2,063,000 -4,123,000 
      restricted cash
    -112,000 13,285,000  145,000 -143,000 13,327,000         
      net incomees (gains) from investment activities
      -1,007,000 8,483,000 16,652,000 5,198,000         
      unrealized gains from investment activities of consolidated public spacs
                  
      changes related to consolidated public spacs:
                  
      cash and cash equivalents related to consolidated public spacs
                  
      assets held in trust accounts
          259,370,000 396,977,000 -2,712,000 349,814,000 -2,549,000 -844,000 -29,000 
      acquisition of angelo gordon
      -657,000 -15,677,000         
      repayments of notes receivable from affiliates
              321,000 14,616,000 
      advances on notes receivable from affiliates
              -1,500,000 -14,000,000 
      proceeds from issuance of common stock in ipo, net of underwriting and issuance costs
              770,865,000 
      proceeds from issuance of common stock from underwriters' exercise of over-allotment option, net of underwriting and issuance costs
              49,756,000 
      purchase of partnership interests with ipo proceeds
              -379,597,000 
      reorganization activities
              2,124,000 
      distributions to holders of other non-controlling interests
                  
      distributions to partners
                  
      redemption of redeemable equity
           -261,001,000       
      unrealized losses from investment activities of consolidated public spacs
                  
      assets held in trust accounts related to consolidated public spacs
                  
      other assets and liabilities, net related to consolidated public spacs
                  
      net (gains) losses from investment activities
                  
      unrealized gains from investment activities of consolidated tpg funds and public spacs
                  
      changes related to consolidated tpg funds and public spacs:
                  
      acquisitions, net of cash acquired
                  
      transfers related to reorganization activities
                  
      net gains from investment activities
           4,203,000 -846,000 -14,816,000     
      unrealized gains on derivative liabilities of public spacs
                  
      deferred borrowing costs
                 
      distributions to holders of other non-controlling interests prior to reorganization and ipo
               -318,942,000 
      distributions to partners prior to reorganization and ipo
               -355,282,000 
      changes related to tpg funds and public spacs:
                  
      unrealized losses (gains) on derivative liabilities of public spacs
            -667,000 750,000     
      proceeds from subordinated credit facility
              30,000,000 
      repayments of subordinated credit facility
              -30,000,000 
      gain from investment activities
              19,286,000 -1,907,000   
      gain on deconsolidation
                  
      net (gains) losses from investment activities of consolidated tpg funds and public spacs
                  
      change in consolidation and other
                  
      acquisition of newquest
                  
      deconsolidation of previously consolidated vehicles
                  
      proceeds from senior unsecured term loan
                  
      borrowings on revolving credit facility to affiliate
                  
      repayments of revolving credit facility to affiliate
                  
      proceeds from sale of non-controlling interests
                  
      net gains from investment activities of consolidated tpg funds and public spacs
               -3,235,000 -5,823,000 -2,657,000 
      gains from investment activities
                 -6,643,000 
      other non-cash amounts
                 16,565,000 
      contributions from holders of non-controlling interests
                  
      distributions to holders of non-controlling interests
                  
      deferred assets
                  
      accrued expenses
                  
      contributions from member
                  
      net change in cash and cash equivalents
                  
      cash and cash equivalents, beginning of period
                  
      cash and cash equivalents, end of period
                  
      assets
                  
      investments
                  
      right-of-use assets
                  
      assets of consolidated tpg funds and public spacs :
                  
      due from counterparty
                  
      total assets
                  
      liabilities, redeemable equity and partners' capital
                  
      liabilities
                  
      secured borrowings
                  
      senior unsecured term loan
                  
      senior unsecured revolving credit facility
                  
      operating lease liabilities
                  
      liabilities of consolidated tpg funds and public spacs :
                  
      securities sold, not yet purchased
                  
      due to counterparty
                  
      derivative liabilities of public spacs
                  
      deferred underwriting
                  
      total liabilities
                  
      commitments and contingencies
                  
      redeemable equity from consolidated public spacs
                  
      partners' capital
                  
      partners' capital controlling interests
                  
      non-controlling interests in consolidated tpg funds
                  
      other non-controlling interests
                  
      total partners' capital
                  
      total liabilities, redeemable equity and partners' capital
                  
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.